0.69 USD
↗ 0.00 (0.29%)AT CLOSE (11:59 AM EDT)
Fractyl Health, Inc. Common Stock
GUTSNASDAQ • USD
0.70
↗ 0.01 (1.46%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
0.70
↗ 0.01 (1.46%)
Market: CLOSED
Shares of Fractyl Health, Inc. Common Stock (GUTS) are trading at $0.69. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, GUTS trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Aug 6, 2026.
Open?$0.69
High?$0.71
Low?$0.69
Prev. Close?$0.69
Volume?764.5K
Avg. Volume?1.6M
VWAP?$0.70
Rel. Volume?0.47x
Bid / Ask
Bid?$0.69 × 18.1K
Ask?$0.70 × 11.2K
Spread?$0.01
Midpoint?$0.70
Valuation & Ratios
Market Cap?109.5M
Shares Out?158.6M
Float?137.2M
Float %?86.5%
P/E Ratio?N/A
P/B Ratio?5.12
EPS?-$0.68
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
Themes
Employees
73
Market Cap
108.7M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
2024-02-02
Address
3 VAN DE GRAAFF DRIVE
BURLINGTON, MA 01803
Phone: 781-902-8800
BURLINGTON, MA 01803
Phone: 781-902-8800
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?65
Piotroski F-Score?0/9Weak
Altman Z-Score?-9.34Distress
Confidence?45%Low
Short InterestLow
Short % of Float?1.84%Low
Short Interest?2.5M
Days to Cover?1.3
Free Float137.2M
Avg Daily Volume1.9M
Settlement Date2026-07-15
Financial Health
Current Ratio?4.28Strong
Quick Ratio?4.28Strong
Cash Ratio?4.10Strong
Debt/Equity?1.41Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?5.12FAIR▾
Peers100
S&P36
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-505.2%WEAK▾
S&P3
ROA?-108.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-87835000
Enterprise Value?$76.4M
Fundamentals ratios updated end of day